Feasibility study of multimodal imaging for redox status and glucose metabolism in tumor
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved..
Understanding the tumor redox status is important for efficient cancer treatment. Here, we noninvasively detected changes in the redox environment of tumors before and after cancer treatment in the same individuals using a novel compact and portable electron paramagnetic resonance imaging (EPRI) device and compared the results with glycolytic information obtained through autoradiography using 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG). Human colon cancer HCT116 xenografts were used in the mice. We used 3-carbamoyl-PROXYL (3CP) as a paramagnetic and redox status probe for the EPRI of tumors. The first EPRI was followed by the intraperitoneal administration of buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis, or X-ray irradiation of the tumor. A second EPRI was performed on the following day. Autoradiography was performed after the second EPRI. After imaging, the tumor sections were evaluated by histological analysis and the amount of reducing substances in the tumor was measured. BSO treatment and X-ray irradiation significantly decreased the rate of 3CP reduction in tumors. Redox maps of tumors obtained from EPRI can be compared with tissue sections of approximately the same cross section. BSO treatment reduced glutathione levels in tumors, whereas X-ray irradiation did not alter the levels of any of the reducing substances. Comparison of the redox map with the autoradiography of [18F]FDG revealed that regions with high reducing power in the tumor were active in glucose metabolism; however, this correlation disappeared after X-ray irradiation. These results suggest that the novel compact and portable EPRI device is suitable for multimodal imaging, which can be used to study tumor redox status and therapeutic efficacy in cancer, and for combined analysis with other imaging modalities.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:218 |
|---|---|
| Enthalten in: |
Free radical biology & medicine - 218(2024) vom: 03. Apr., Seite 57-67 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kato, Kazuhiro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoradiography |
|---|
| Anmerkungen: |
Date Revised 07.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.freeradbiomed.2024.03.028 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370644034 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370644034 | ||
| 003 | DE-627 | ||
| 005 | 20240408233007.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240405s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.freeradbiomed.2024.03.028 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM370644034 | ||
| 035 | |a (NLM)38574976 | ||
| 035 | |a (PII)S0891-5849(24)00165-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kato, Kazuhiro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Feasibility study of multimodal imaging for redox status and glucose metabolism in tumor |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Understanding the tumor redox status is important for efficient cancer treatment. Here, we noninvasively detected changes in the redox environment of tumors before and after cancer treatment in the same individuals using a novel compact and portable electron paramagnetic resonance imaging (EPRI) device and compared the results with glycolytic information obtained through autoradiography using 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG). Human colon cancer HCT116 xenografts were used in the mice. We used 3-carbamoyl-PROXYL (3CP) as a paramagnetic and redox status probe for the EPRI of tumors. The first EPRI was followed by the intraperitoneal administration of buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis, or X-ray irradiation of the tumor. A second EPRI was performed on the following day. Autoradiography was performed after the second EPRI. After imaging, the tumor sections were evaluated by histological analysis and the amount of reducing substances in the tumor was measured. BSO treatment and X-ray irradiation significantly decreased the rate of 3CP reduction in tumors. Redox maps of tumors obtained from EPRI can be compared with tissue sections of approximately the same cross section. BSO treatment reduced glutathione levels in tumors, whereas X-ray irradiation did not alter the levels of any of the reducing substances. Comparison of the redox map with the autoradiography of [18F]FDG revealed that regions with high reducing power in the tumor were active in glucose metabolism; however, this correlation disappeared after X-ray irradiation. These results suggest that the novel compact and portable EPRI device is suitable for multimodal imaging, which can be used to study tumor redox status and therapeutic efficacy in cancer, and for combined analysis with other imaging modalities | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Autoradiography | |
| 650 | 4 | |a Cancer therapy | |
| 650 | 4 | |a Electron paramagnetic resonance imaging (EPRI) | |
| 650 | 4 | |a Multimodal imaging | |
| 650 | 4 | |a Tumor redox status | |
| 700 | 1 | |a Yasui, Hironobu |e verfasserin |4 aut | |
| 700 | 1 | |a Sato-Akaba, Hideo |e verfasserin |4 aut | |
| 700 | 1 | |a Emoto, Miho C |e verfasserin |4 aut | |
| 700 | 1 | |a Fujii, Hirotada G |e verfasserin |4 aut | |
| 700 | 1 | |a Kmiec, Maciej M |e verfasserin |4 aut | |
| 700 | 1 | |a Kuppusamy, Periannan |e verfasserin |4 aut | |
| 700 | 1 | |a Mizuno, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kuge, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Nagane, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Yamashita, Tadashi |e verfasserin |4 aut | |
| 700 | 1 | |a Inanami, Osamu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Free radical biology & medicine |d 1989 |g 218(2024) vom: 03. Apr., Seite 57-67 |w (DE-627)NLM012613827 |x 1873-4596 |7 nnns |
| 773 | 1 | 8 | |g volume:218 |g year:2024 |g day:03 |g month:04 |g pages:57-67 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.freeradbiomed.2024.03.028 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 218 |j 2024 |b 03 |c 04 |h 57-67 | ||